Viper Equity Partners Moves Plastic Surgery Into Consolidation Mainstream with Another Marquis Deal

Plastic Surgery is moving into the consolidation Mainstream with another marquis deal by Viper Equity Partners of Palm Beach, FL.

Viper was instrumental in a Marquis deal merging their client Aqua Plastic Surgery with Water's Edge Dermatology backed by Gryphon Investors of San Francisco.

Aqua, a  plastic surgery practice with three offices in Jupiter, Fort Lauderdale, and Miami, Florida, will augment the skin cancer and reconstructive surgical capability of Water's Edge, a provider of comprehensive dermatology services through 37 Florida locations. Led by plastic surgeon David Rankin, MD, Aqua will continue to operate under its existing name. "I am so happy to partner with Water's Edge. The business of plastic surgery coming together with dermatology was inevitable. We have aggressive plans for the future, and I am happy to be part of this stellar team," says Dr. Rankin in a news release. "Viper's vision was instrumental in facilitating my deal and will be a key transition resource moving forward for plastic surgeons nationwide."

"Viper is the front-running boutique M&A intermediary making consolidation of plastic surgery as mainstream as dentistry, a space we dominate," says Viper Founder and Principal David Branch. “So far, Viper has aligned itself with cutting-edge plastic surgery offices in Chicago, New York City, and South Florida to create 3 geographically friendly verticals for private equity focus. Florida has launched, and New York City offices are under contract.”

Nina Das, Viper's Vice President of M&A, adds: "The bottom line is that plastic surgeons have highly profitable and branded practices built for scale, easy to cross over into dermatology, and plain sailing to roll up. I am delighted to be heading the charge at Viper to aid dermatology platforms acquire plastic surgery and dermatology practices in the Southeast, and I look forward to growing our novel Dermatology and Plastic Surgery Division with our private equity-backed partners who understand that cosmetic surgery and skincare are not only critical to consumers but also a phenomenal consolidation play."